Jung-Eun Cheon
Biographic Data
| ID | 10414657 |
|---|---|
| NAME | Jung-Eun Cheon |
| GIVEN NAMES | Jung-Eun |
| FAMILY NAME | Cheon |
| SIGNATURE | CHEON J |
| AFFILIATIONS | Department of Radiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
The Impact of 131I-Metaiodobenzylguanidine as a Conditioning Regimen of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma
Although tandem HDC/ASCT showed promising outcomes, the 131 I-MIBG combination did not improve survival rates
Twenty-Year Retrospective Study of Post-Enucleation Chemotherapy in High-Risk Patients with Unilateral Retinoblastoma
Primary enucleation is a life-saving treatment for advanced intraocular retinoblastoma, particularly in patients with poor visual potential and functional contralateral eyes. This single-center study presents the treatment outcomes of patients with unilateral retinoblastoma who received primary enucleation and adjuvant chemotherapy with cyclophosphamide, vincristine, doxorubicin, and intrathecal methotrexate (CVDM) between 2000 and 2020. Twenty p…
No prominent works on this page.
Twenty-Year Retrospective Study of Post-Enucleation Chemotherapy in High-Risk Patients with Unilateral Retinoblastoma
Primary enucleation is a life-saving treatment for advanced intraocular retinoblastoma, particularly in patients with poor visual potential and functional contralateral eyes. This single-center study presents the treatment outcomes of patients with unilateral retinoblastoma who received primary enucleation and adjuvant chemotherapy with cyclophosphamide, vincristine, doxorubicin, and intrathecal methotrexate (CVDM) between 2000 and 2020. Twenty p…
The Impact of 131I-Metaiodobenzylguanidine as a Conditioning Regimen of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma
Although tandem HDC/ASCT showed promising outcomes, the 131 I-MIBG combination did not improve survival rates
Chemotherapy (2 works) · Medicine (2 works) · Autologous stem-cell transplantation (1 works) · Biology (1 works) · Cancer therapeutics and mechanisms (1 works) · Cancer, Hypoxia, and Metabolism (1 works) · Cell culture (1 works) · Conditioning regimen (1 works) · Corneal Surgery and Treatments (1 works) · Cyclophosphamide (1 works)